Price T Rowe Associates Inc Reata Pharmaceuticals Inc Transaction History

Price T Rowe Associates Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$79.22 - $105.37 $104,887 - $139,509	-1,324 Reduced 0.45%	295,741 $30.2 Million
Q1 2023 May 15, 2023	BUY	$30.85 - $93.17 $8.57 Million - $25.9 Million	277,696 Added 1433.71%	297,065 $27 Million
Q4 2022 Feb 14, 2023	BUY	$22.15 - $42.11 $7,154 - $13,601	323 Added 1.7%	19,369 $736,000
Q3 2022 Nov 14, 2022	SELL	$19.41 - $36.49 $9.35 Million - $17.6 Million	-481,724 Reduced 96.2%	19,046 $479,000
Q2 2022 Aug 15, 2022	SELL	$20.71 - $36.5 $1.28 Million - $2.26 Million	-61,979 Reduced 11.01%	500,770 $15.2 Million
Q1 2022 May 16, 2022	SELL	$24.12 - $39.6 $9.73 Million - $16 Million	-403,262 Reduced 41.75%	562,749 $18.4 Million
Q4 2021 Feb 14, 2022	SELL	$25.61 - $110.96 $2.32 Million - $10.1 Million	-90,776 Reduced 8.59%	966,011 $25.5 Million
Q3 2021 Nov 15, 2021	SELL	$100.0 - $143.02 $828,700 - $1.19 Million	-8,287 Reduced 0.78%	1,056,787 $106 Million
Q2 2021 Aug 16, 2021	BUY	$78.27 - $151.29 $887,738 - $1.72 Million	11,342 Added 1.08%	1,065,074 $151 Million
Q1 2021 May 17, 2021	SELL	$94.25 - $132.81 $6.33 Million - $8.92 Million	-67,190 Reduced 5.99%	1,053,732 $105 Million
Q4 2020 Feb 16, 2021	BUY	$102.03 - $184.62 $114 Million - $207 Million	1,120,922 New	1,120,922 $139 Million

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.